Rochelle B. Lazarus, Director at Merck & Co., Inc. (MRK), sold 20,000 shares at $59.06 ($1.2M) on 2016-11-02, disclosed to the SEC on 2016-11-02.
Open-market sale of $1.2M MRK by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GE | BUY | 2006-01-27 | $10K | — | Filing → |